When combined with adoptive transfer of ex-vivo gp100-stimulated Pmel-1 T cells, IL-2/NARA1 was more effective at expanding these TAA-specific T cells in tumor-draining lymph nodes and tumors compared to PBS- or recombinant human IL-2-treated mice (121). This evidence concerns the gene IL2 and neoplasm.